Innovotech Inc. · TSXV:IOT
Innovotech — Investor Presentation (May 2025)
18 slides from Innovotech's investor presentation, May 2025
Slide 1: Corporate Presentation Q1 2025
Corporate Presentation Q1 2025 TSXV: IOT
Slide 2: Executive Summary
Executive Summary Innovotech is a Canadian microcap biotech company with deep client relationships, 20+ years of technical expertise, proprietary methods and intellectual property. Our strategy is to build a diverse portfolio of revenue generating business lines while supporting targeted research fo
Slide 3: IOT Performance
IOT Performance Revenue growth driven by large contract research projects & acquisition of Keystone Labs in November 2024. Strong balance sheet ● $3.4mm assets ● No term debts
Slide 4: Market Opportunity
Market Opportunity Growth Drivers Antimicrobial susceptibility testing Market $4.5B2 • Antimicrobial resistance is a growing concern with increasing pressure on medical device manufacturers for innovative solutions Market • Biofilm science is still in its infancy and Opportunity Innovotech has been
Slide 5: IOT is organized into operating companies and business streams
IOT is organized into operating companies and business streams Innovotech Inc. Innovotech Labs Corporation Keystone Labs Corporation NouLife Sciences Inc. • Contract Research Services • Analytical and • R&D and Commercialization microbiology services of antioxidant technologies • Production and sale
Slide 6: Stream 1: Microbiology-related Contract Research Services
Stream 1: Microbiology-related Contract Research Services • Innovotech is a leader in contract research services, focusing on microbial interactions with biosurfaces and antimicrobial effectiveness. • Innovotech provides research support and third-party testing, as companies develop new coatings or
Slide 7: Stream 2: MBEC Assay Kits
Stream 2: MBEC Assay® Kits Consumable Lab Supplies Required for Standard Antibiofilm Tests • Typical purchasers are industrial researchers, academia and governments • Basis for ASTM E2799 Method • Worldwide sales direct from our webstore, innovotech.ca • Innovotech retains proprietary manufacturing
Slide 8: Stream 2: MBEC Assay Kits Shipped Globally
Stream 2: MBEC Assay® Kits Shipped Globally
Slide 9: Stream 3: InnovoSIL-1 Antimicrobial silver commercialization
Stream 3: InnovoSIL™ -1 Antimicrobial silver commercialization • New class of silver-iodine complexes • Broad spectrum activity: shown to be effective against mature biofilms, superbugs and respiratory viruses, including COVID-19 • Slow-release properties allow for continuous release to prevent adhe
Slide 10: Stream 4: Analytical and Microbiology Services
Stream 4: Analytical and Microbiology Services Sterility & Micro Environmental Monitoring Method Development Ensure products meet the Manage the product environment Improve existing methods or highest standards of microbial and comply with regulations. create a new approach. safety and cleanliness.
Slide 11: Stream 5: NouLife Sciences Inc.
Stream 5: NouLife Sciences Inc. • Technology for advanced penetration of linked antioxidant molecules for diabetic neuropathy and cosmetic applications • Successfully synthesized linked molecule with 3 linkers • Completed stability studies • Ongoing permeability studies • Seeking commercialization p
Slide 12: IOT Outlook
IOT Outlook Continuation of contract research projects through 2025 Expansion of contract research services offered from R&D - encrustation assays Growth in analytical chemistry and method development projects enabled by an additional stability chamber and HPLC capacity adds long-term, recurring rev
Slide 13: IOT R&D
IOT R&D Innovotech is continuing a focused program of R&D to expand the line of products and services in these key areas: InnovoSIL™-1 Contract Research MBEC Assay® Kits NouLife Sciences Silver Development • Further scale-up of • Development and validation of • Evaluating a new plate design • Contin
Slide 14: Quality & Credibility
Quality & Credibility • Accredited by CALA to ISO/IEC 17025 testing accreditation number A4146. Enumerating Bacteria - solids. Enumeration Bacteria - Liquids • Keystone Labs is a Health Canada accredited GMP regulated facility with a Drug Establishment license • Innovotech is recognized as the devel
Slide 15: Quality & Credibility
Quality & Credibility • Innovotech developed the BEST Assay™ Method - an industry-leading approach used to study antimicrobial surface coatings on various medical devices • Innovotech has generated data for clients that has been used by the FDA for product regulatory approvals • Innovotech and it’s
Slide 16: Board and Management
Board and Management Craig Milne Tyler Boone Jodi McDonald Patricia Nadworny Bernard Grobbelaar MBA, Ph.D., CEO, Director Ph.D., COO BSc., President, Keystone Labs Ph.D., P.Eng., CSO CPA, CFO Operations leader with Entrepreneurial leader Chemical & biomedical CPA/CA with more than Entrepreneurial le
Slide 17: Cautionary Note Regarding Forward-Thinking Statements
Cautionary Note Regarding Forward-Thinking Statements This document may contain forward-looking statements that are predictive in nature and subject to risks and uncertainties that cannot be predicted or quantified; consequently, actual results may differ materially from past results and those expre
Slide 18: Contact Us
Contact Us Craig Milne 1-604-239-1819 craig.milne@innovotech.ca Innovotech.ca Corporate Presentation Q1-2025